ASM vs. SRPT

In the year-to-date period, ASM achieves a 74.60% return, which is significantly higher than SRPT's 24.70% return. Over the past 10 years, ASM has underperformed SRPT with an annualized return of -3.16%, while SRPT has yielded a comparatively higher 24.78% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Avino Silver & Gold Mines Ltd. (ASM) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ASM Sharpe Ratio is 1.24, which is higher than the SRPT Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of ASM and SRPT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ASM nor SRPT has paid dividends to shareholders.

The maximum ASM drawdown since its inception was -94.10%, roughly equal to the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for ASM and SRPT. For additional features, visit the drawdowns tool.

Avino Silver & Gold Mines Ltd. (ASM) and Sarepta Therapeutics, Inc. (SRPT) have volatilities of 17.53% and 17.29%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Avino Silver & Gold Mines Ltd. and Sarepta Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.